Cite
Tu1926 Evolution After Anti-TNF Drug Discontinuation in Patients With Inflammatory Bowel Disease (IBD): A Multicenter Long-Term Follow-Up Study
MLA
María José Casanova, et al. “Tu1926 Evolution After Anti-TNF Drug Discontinuation in Patients With Inflammatory Bowel Disease (IBD): A Multicenter Long-Term Follow-Up Study.” Gastroenterology, vol. 150, Apr. 2016, p. S979. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........719a6e0641fbcd861c173932dc48cfc3&authtype=sso&custid=ns315887.
APA
María José Casanova, María Chaparro, Valle García-Sánchez, Óscar Nantes, Eduardo Leo, María Rojas-Feria, Aranzazu Jauregui-Amezaga, Santiago García-López, José María Huguet, Federico Argüelles-Arias, Marta Aicart, Ignacio Marin-Jimenez, M Gómez-García, Fernando Muñoz, María Esteve, Luis Bujanda, Xavier Cortés, Joan Tosca, Juan Ramón Pineda, … Javier P. Gisbert. (2016). Tu1926 Evolution After Anti-TNF Drug Discontinuation in Patients With Inflammatory Bowel Disease (IBD): A Multicenter Long-Term Follow-Up Study. Gastroenterology, 150, S979.
Chicago
María José Casanova, María Chaparro, Valle García-Sánchez, Óscar Nantes, Eduardo Leo, María Rojas-Feria, Aranzazu Jauregui-Amezaga, et al. 2016. “Tu1926 Evolution After Anti-TNF Drug Discontinuation in Patients With Inflammatory Bowel Disease (IBD): A Multicenter Long-Term Follow-Up Study.” Gastroenterology 150 (April): S979. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........719a6e0641fbcd861c173932dc48cfc3&authtype=sso&custid=ns315887.